SCHEMBL4129464

SCHEMBL4129464

COC(=O)C1CCCCC(c2ccnc(C)c2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.37
USP30 Q70CQ3 1/20 0.36
PROKR1 Q8TCW9 2/20 0.36
TLR8 Q9NR97 2/20 0.33
TLR7 Q9NYK1 2/20 0.33
ABL1 P00519 1/20 0.33
BDKRB1 P46663 1/20 0.33
MAPK1 P28482 1/20 0.33
TSHR P16473 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 1/20 0.32
TLR9 Q9NR96 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4059047 0.78 TP53 (0.49) TSHRTP53KDM4ESLC6A2SLC6A4
SCHEMBL4136122 0.75 TP53 (0.52) TSHRTP53KDM4ESLC6A2SLC6A4
SCHEMBL4135366 0.72 ATM (0.43) SMN1; SMN2ALDH1A1
SCHEMBL4127785 0.72 TLR4 (0.38) IDO1USP30PROKR1MAPK1KDM4E
SCHEMBL5897010 0.69 POLB (0.46) TSHRSMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL5897596 0.69 POLB (0.45) TSHRTP53KDM4ESLC6A2SLC6A4
SCHEMBL3974812 0.68 CYP1A2 (0.43) MAPK1SMN1; SMN2ALDH1A1
SCHEMBL3362070 0.68 CYP1A2 (0.38) MAPK1SMN1; SMN2KDM4EALDH1A1SLC6A2
SCHEMBL12093743 0.67 IDO1 (0.45) IDO1USP30PROKR1TLR8TLR7
SCHEMBL5897594 0.67 MMP1 (0.46) MAPK1SMN1; SMN2TP53KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436005-B2 Macrocyclic pyrimidine derivatives ABBOTT LABORATORIES (US) 2013-05-07 US disclosed
WO-2009123967-A1 5,6,7,8-TETRAHYDROQUINAZOLIN-2-AMINE DERIVATIVES AND RELATED COMPOUNDS AS HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ASTHMA ABBOTT LABORATORIES (US) 2009-10-08 WO disclosed
US-20090253678-A1 MACROCYCLIC PYRIMIDINE DERIVATIVES ABBOTT LABORATORIES (US) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253678-A1 MACROCYCLIC PYRIMIDINE DERIVATIVES DPYD, TYMS, TYMP IDO1 3003/4885USP30 3743/4885PROKR1 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.